197516
Partner violence screening effectiveness in a reproductive health care setting
Wednesday, November 11, 2009: 10:30 AM
Gabriela Santana Betancourt, MA, MPH
,
Dept of Planning, Research and Evaluation, Planned Parenthood New York City, New York, NY
Lisa Colarossi, PhD
,
Planned Parenthood of New York City, New York, NY
Traditional intimate partner violence (IPV) screening tools have been developed and tested in emergency room settings, and their integration into health clinics has been scarcely documented This study tests the effectiveness of a newly developed, evidenced-based IPV screening tool for identification rates of IPV among reproductive health patients. The new screening procedures are compared to an older, traditional, screening procedure. This study provides evidence that can be used for screening and assisting women in a clinic setting before a crisis emerges (such as in an emergency room). A retrospective, cohort design compares two groups of patients receiving the old and new screening protocols to determine differences in disclosure rates and whether these rates vary by age, racial or ethnic group, and/or neighborhood clinic site. Data was obtained from 600 medical charts that were randomly selected from three clinics at Planned Parenthood of New York City (300 charts of clients who were screened under the new procedures and 300 screened with an older method). Preliminary results indicate that the new screening tool identifies more IPV cases (18% of patients) compared to the old form (9%) and that it has the ability to detect more subtle forms of violence like threatening behavior. There were no differences between forms in rates of refusal to answer the questions. Age and race differences exist in disclosure rates and follow-up procedures. Further, disclosure rates of past versus current relationship violence are discussed.
Learning Objectives: Name an evidence based intimate partner violence screening tool used in urban comprehensive reproductive health centers.
Describe procedures associated with using the screening tool.
Describe the differences in disclosure rates of partner violence between two different screening tools and associated age and race differences.
Discuss implications for partner violence screening in primary care and reproductive health care settings.
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I have a doctorate degree, extensive experience in clinical settings, and several peer-reviewed publications on IPV.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|